California Senate Bill 646
Session 20252026
Prenatal multivitamins.
Active
Passed Assembly on Sep 13, 2025
Origin Chamber
Senate
Type
Bill
Bill Number
646
State
California
Session
20252026
Motion Text
Unfinished Business SB646 Weber Pierson Concurrence
Senate Roll Call Votes
Yes
Other
Yes
Yes
Yes
Other
Other
Yes
Yes
Other
Yes
Summary
Existing law, the Sherman Food, Drug, and Cosmetic Law, under the administration and enforcement of the State Department of Public Health, provides for the regulation of various subjects relating to the manufacturing, processing, labeling, advertising, and sale of food, drugs, and cosmetics. A violation of the Sherman Food, Drug, and Cosmetic Law is punishable as a misdemeanor.
Existing law requires a manufacturer of baby food for sale or distribution in this state to test a representative sample of each production aggregate of the manufacturer's final baby food product for toxic elements, as specified. Existing law requires a manufacturer to provide test results to any authorized agent of the department upon their request, as specified. Existing law requires a manufacturer of a final baby food product sold, manufactured, delivered, held, or offered for sale in the state to provide specified information disclosures to consumers, including making publicly available on its internet website the name and level of each toxic element present in each production aggregate of the final baby food product. Existing law also prohibits a person or entity from selling in the state or manufacturing, delivering, holding, or offering for sale in the state any baby food that does not comply with these provisions.
This bill would require, commencing January 1, 2027, a manufacturer of a bulk prenatal multivitamin product or packaged prenatal multivitamin product, as defined, that is sold, manufactured, delivered, held, or offered for sale in this state to test a representative sample of each lot of the manufacturer's bulk prenatal multivitamin product or packaged prenatal multivitamin product for heavy metals, as specified. The bill would define "heavy metals" to mean arsenic, cadmium, lead, and mercury. The bill would require both a manufacturer and brand owner to provide test results to an authorized agent of the department upon their request, as specified. The bill would, commencing January 1, 2027, require a brand owner of a packaged prenatal multivitamin product that is sold, manufactured, delivered, held, or offered for sale in the state, as specified, to disclose specified product information to the public, including, among other things, the heavy metal testing information. Commencing on or after January 1, 2027, for products shipped to retailers or consumers, the bill would require the outermost package of a packaged prenatal vitamin product and the product details page on an internet website where the product is sold to include a statement regarding heavy metal testing. The bill would prohibit a person from selling in the state or manufacturing, delivering, holding, or offering for sale in the state a prenatal multivitamin that does not comply with these provisions. By creating a new crime, the bill would impose a state-mandated local program.
The California Constitution requires the state to reimburse local agencies and school districts for certain costs mandated by the state. Statutory provisions establish procedures for making that reimbursement.
This bill would provide that no reimbursement is required by this act for a specified reason.
02/20/25 - Introduced
February 20, 2025
03/24/25 - Amended Senate
March 24, 2025
04/10/25 - Amended Senate
April 10, 2025
06/16/25 - Amended Assembly
June 16, 2025
07/07/25 - Amended Assembly
July 7, 2025
07/10/25 - Amended Assembly
July 10, 2025
09/05/25 - Amended Assembly
September 5, 2025
09/09/25 - Amended Assembly
September 9, 2025
09/18/25 - Enrolled
September 18, 2025
04/01/25- Senate Health
April 1, 2025
04/28/25- Senate Environmental Quality
April 28, 2025
05/09/25- Senate Appropriations
May 9, 2025
05/26/25- Sen. Floor Analyses
May 26, 2025
06/27/25- Assembly Health
June 27, 2025
07/12/25- Assembly Environmental Safety and Toxic Materials
July 12, 2025
08/18/25- Assembly Appropriations
August 18, 2025
09/02/25- ASSEMBLY FLOOR ANALYSIS
September 2, 2025
09/05/25- ASSEMBLY FLOOR ANALYSIS
September 5, 2025
09/09/25- ASSEMBLY FLOOR ANALYSIS
September 9, 2025
09/13/25- Sen. Floor Analyses
September 13, 2025
Sort by most recent
09/23/2025
California State Legislature
Enrolled and presented to the Governor at 2 p.m.
09/13/2025
Senate
Assembly amendments concurred in. (Ayes 34. Noes 0.) Ordered to engrossing and enrolling.
09/13/2025
Senate
In Senate. Concurrence in Assembly amendments pending.
09/13/2025
Assembly
Read third time. Passed. Ordered to the Senate.
09/13/2025
Assembly
Joint Rule 61(a)(14) and 51(a)(4) suspended.
09/09/2025
Assembly
Ordered to third reading.
09/09/2025
Assembly
Read third time and amended.
09/09/2025
Assembly
Joint Rule 61(a)(13) suspended.
09/05/2025
Assembly
Ordered to third reading.
09/05/2025
Assembly
Read third time and amended.
09/05/2025
Assembly
Assembly Rule 69(b)(1) suspended.
09/02/2025
Assembly
Read second time. Ordered to third reading.
08/29/2025
Assembly
From committee: Do pass. (Ayes 15. Noes 0.) (August 29).
08/20/2025
Assembly
August 20 set for first hearing. Placed on APPR. suspense file.
07/16/2025
Assembly
From committee: Do pass and re-refer to Com. on APPR. (Ayes 5. Noes 0.) (July 15). Re-referred to Com. on APPR.
07/10/2025
Assembly
From committee with author's amendments. Read second time and amended. Re-referred to Com. on E.S & T.M.
07/07/2025
Assembly
Read second time and amended. Re-referred to Com. on E.S & T.M.
07/03/2025
Assembly
From committee: Do pass as amended and re-refer to Com. on E.S & T.M. (Ayes 15. Noes 0.) (July 1).
06/16/2025
Assembly
From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
06/05/2025
Assembly
Referred to Coms. on HEALTH and E.S & T.M.
05/28/2025
Assembly
In Assembly. Read first time. Held at Desk.
05/28/2025
Senate
Read third time. Passed. (Ayes 38. Noes 0. Page 1305.) Ordered to the Assembly.
05/23/2025
Senate
Read second time. Ordered to third reading.
05/23/2025
Senate
From committee: Do pass. (Ayes 6. Noes 0. Page 1208.) (May 23).
05/16/2025
Senate
Set for hearing May 23.
05/12/2025
Senate
May 12 hearing: Placed on APPR. suspense file.
05/02/2025
Senate
Set for hearing May 12.
05/01/2025
Senate
From committee: Do pass and re-refer to Com. on APPR. (Ayes 8. Noes 0. Page 964.) (April 30). Re-referred to Com. on APPR.
04/10/2025
Senate
From committee with author's amendments. Read second time and amended. Re-referred to Com. on E.Q.
04/08/2025
Senate
Set for hearing April 30.
04/03/2025
Senate
From committee: Do pass and re-refer to Com. on E.Q. (Ayes 11. Noes 0. Page 636.) (April 2). Re-referred to Com. on E.Q.
03/24/2025
Senate
From committee with author's amendments. Read second time and amended. Re-referred to Com. on HEALTH.
03/17/2025
Senate
Set for hearing April 2.
03/05/2025
Senate
Referred to Coms. on HEALTH and E.Q.
02/21/2025
Senate
From printer. May be acted upon on or after March 23.
02/20/2025
Senate
Introduced. Read first time. To Com. on RLS. for assignment. To print.
Sources
Record Created
Feb 21, 2025 6:05:14 AM
Record Updated
Sep 25, 2025 8:35:03 AM